Leveraged and inverse ETF's are a very practical hedging tool that I have been using for many years. I am an experienced (over 40 years) professional investor that understands the mechanics of how and when these tools work, their shortcomings and their costs. Absent these cheap and very liquid tools, the cost to hedge an equity (or bond) portfolio can be very costly and time consuming. I agree that these investment products may be dangerous in the hands of an inexperienced investor, but that is not an argument to ban them. The only investment company that I know of that has banned these products is Vanguard and I have voiced my displeasure to them in this regard. I do find it strange that regulators are addressing this purported problem when I haven't seen any controversy covering this topic in the Wall Street Journal, Barron's or Business Week.
For the Public
FINRA DATA
FINRA Data provides non-commercial use of data, specifically the ability to save data views and create and manage a Bond Watchlist.
For Industry Professionals
FINPRO
Registered representatives can fulfill Continuing Education requirements, view their industry CRD record and perform other compliance tasks.
For Member Firms
FINRA GATEWAY
Firm compliance professionals can access filings and requests, run reports and submit support tickets.
For Case Participants
DR PORTAL
Arbitration and mediation case participants and FINRA neutrals can view case information and submit documents through this Dispute Resolution Portal.
Need Help? | Check System Status
Log In to other FINRA systems
Peter McCarthy Comment On Regulatory Notice 22-08
Leveraged and inverse ETF's are a very practical hedging tool that I have been using for many years. I am an experienced (over 40 years) professional investor that understands the mechanics of how and when these tools work, their shortcomings and their costs. Absent these cheap and very liquid tools, the cost to hedge an equity (or bond) portfolio can be very costly and time consuming. I agree that these investment products may be dangerous in the hands of an inexperienced investor, but that is not an argument to ban them. The only investment company that I know of that has banned these products is Vanguard and I have voiced my displeasure to them in this regard. I do find it strange that regulators are addressing this purported problem when I haven't seen any controversy covering this topic in the Wall Street Journal, Barron's or Business Week.